Professional Documents
Culture Documents
6 April 2009
Evidence-based Medicine for Surgeons
Flexible sigmoidoscopy and whole colonic imaging in the diagnosis of cancer in patients with
colorectal symptoms
EBM-O-METER
Evidence level Bias level Bias levels
Double blind RCT Sampling
Randomized controlled trial (RCT) Comparison
Trash Swiss Safe News-
Prospective cohort study - not randomized cheese worthy Measurement
Life's too Holds water
short for this Full of holes “Just do it”
Case controlled study
Interestingl | Novel l | Feasible l
Case series - retrospective Ethical l | Resource saving l
© Dr Arjun Rajagopalan
SAMPLING
Sample type Inclusion criteria Exclusion criteria Final score card
Simple random All patients referred to Already diagnosed Study
a colorectal clinic for before referral
Stratified random Target -
evaluation of Anorectal disease on
Cluster symptoms and signs rectal exam Accessible 17271
suggestive of colorectal
Consecutive cancer, between 1986 Intended 16433
Convenience and 2001 Drop outs 0
Judgmental Study 16433
COMPARISON
Randomized Case-control Non-random Historical None
Controls - details
Allocation details Patients were stratified at presentation into two groups: those presenting with an abdominal
mass and/or iron deficiency anemia and those presenting only with symptoms (rectal
bleeding, change in bowel habits or abdominal pain).
Flexible sigmoidoscopy was performed on all patients with either no bowel preparation or a a
self-administered phosphate enema. Patients were submitted to whole colon imaging (barium
enema, colonoscopy or CT colonography) on a subjective, arbitrary basis. Clinical history, and
findings on investigations were recorded in a pro forma.
Comparability -
Disparity -
Comparison bias: An ideal study would involve each patient serving as his or her own control. This would involve
performing FS first and then submitting the patient to a WCI performed or read by another investigator who was not
aware of the results of FS. Only then can the critical question - how many cancers were missed - be answered with
certainty. In this study, only 5665 of the cohort of 16433 patients received both FS and WCI. We are left with the
assumption that the 10000 plus remaining patients were only available for assessment as "missed" cancers,
assuming that they were all available for long term follow up, the details of which are sketchy in this paper.
MEASUREMENT
Measurement error
Device used Device error Observer error
Gold std.
Scoring
Blinding
Repetition
Protocols
Y ? N
Measurement bias: No specific data is offered on the completeness of this all important element.
© Dr Arjun Rajagopalan